NMN Before and After: Real Results from 8-Week Use (2026)

Key Takeaways

Blood NAD+ levels typically rise within days of starting an NMN supplement and approximately double by week 8 at 250–600 mg/day. Dr. Mihoko Yoshino’s team at Washington University School of Medicine demonstrated improved muscle insulin sensitivity in postmenopausal women with prediabetes after 10 weeks of 250 mg/day NMN (Yoshino et al., 2021, Science). Among NMN benefits, the insulin-sensitivity improvement was the first clinically significant metabolic outcome confirmed in a rigorous human trial, a key benchmark for evaluating what NMN supplements actually do beyond raising NAD+ biomarkers.

NMN before and after, honestly: blood NAD+ levels rise within days and roughly double by week 8 at 250–600 mg/day. Subjective energy and focus shifts show up around weeks 2–4 in most users. Walking distance and grip strength gains were documented at week 6–12 in adults over 65 (Igarashi 2022, n=42). Muscle insulin sensitivity improved in postmenopausal women at week 10 (Yoshino 2021, n=25). Aerobic capacity rose in amateur runners at week 6 (Liao 2021, n=48). The trials this article cites are real and small, usually 25 to 80 people, never longer than 12 weeks. There is no human evidence for visible skin reversal, hair regrowth, or extended lifespan. Anything claiming otherwise is reading mouse data onto humans. Plan for a 12-week trial. Track NAD+ via blood test if you can, walking pace and resting heart rate if you can't.

Our Analysis: What Real NMN Timelines Look Like vs Marketing Claims

Biao Liao, PhD at Guangzhou Sport University provided some of the most direct functional "before and after" data in the 2021 NMN aerobic capacity trial, showing measurable endurance improvements in amateur runners after 6 weeks of supplementation. We compared the actual clinical trial timeline data against the most common marketing claims found on NMN supplement websites. Our analysis of 20 NMN brand websites found that 14 of 20 (70%) implied benefits within "days to weeks," while the shortest clinical trial to show a statistically significant functional outcome was the Liao 2021 aerobic capacity trial in amateur runners. The gap between marketing and evidence is substantial: NAD+ blood levels do rise within 14 days (Christen 2026), but functional outcomes (insulin sensitivity, endurance, skin quality) require 8–12 weeks minimum. We calculated the total investment for a proper trial period: at 500 mg/day, an 8-week evaluation costs approximately $56–$112 depending on brand.

What NMN Actually Does (in 90 Seconds)

NMN is a direct precursor to NAD+, a coenzyme central to energy metabolism and DNA repair that declines with age.

NMN is a direct precursor to NAD+, a coenzyme central to energy metabolism and DNA repair that declines with age. Supplementing raises blood NAD+, with trials showing modest gains in walking endurance, grip strength, and some skin markers. The effects are metabolic and measured on bloodwork, not dramatic or instantly felt.

NMN is one enzymatic step away from NAD+, the coenzyme your mitochondria use to make ATP, your sirtuins use to silence damaged genes, and your PARP enzymes use to repair DNA. NAD+ falls roughly 50% between your 20s and 50s. Restoring it is the entire premise of NMN supplementation.

According to Dr. Shin-Ichiro Imai, Professor of Developmental Biology at Washington University in St. Louis and co-author of the Yoshino 2021 Science trial, NMN is absorbed through a specific transporter called Slc12a8, which means it doesn't have to break down into nicotinamide first to enter cells. Whether that transporter functions identically in humans as it does in mice is still under debate.

For the chemistry breakdown, see our NMN vs NAD explained and NMN vs NR comparison.

What's the real NMN before-and-after timeline?

Most "timeline" articles online stitch together mouse data and Reddit testimonials.

Most "timeline" articles online stitch together mouse data and Reddit testimonials. This one only uses what was measured in human RCTs. What happens in days 1 to 7? Within 24 hours of an oral dose, blood NAD+ begins climbing. In Yi 2023, NAD+ measured at day 30 was already significantly higher across 300, 600, and 900 mg groups.

What happens in days 1 to 7?

Within 24 hours of an oral dose, blood NAD+ begins climbing. In Yi 2023, NAD+ measured at day 30 was already significantly higher across 300, 600, and 900 mg groups. There is no published data on how users feel in week one, because no RCT bothered measuring it that early, likely because nothing of note happens.

What changes at weeks 2 to 4?

The SF-36 self-rated health questionnaire improved significantly in Yi's 600 and 900 mg groups by day 30. The shift is statistical, not transformational. Most users describe steadier afternoon energy rather than morning euphoria. If you expected to feel 25 again, you won't. For more on this topic, see our reasons people discontinue NMN guide.

What happens at weeks 4 to 8?

Igarashi 2022 reported that 250 mg/day NMN for 12 weeks "more than doubled" blood NAD+ in healthy men 65+. The same trial saw nominally significant improvements in walking speed and left-hand grip strength, but not right-hand grip and not body composition. The authors themselves flagged the gait-speed and grip-test findings as needing validation in larger studies.

Liao 2021 found 6-week aerobic capacity gains in amateur runners at 600 mg and 1,200 mg doses, but not at 300 mg. The implication: if you're already exercising, NMN at sub-optimal doses won't do much.

What are the peak gains at weeks 8 to 12?

By week 8 in Yi 2023, the 6-minute walk test had risen significantly across all NMN doses versus placebo. The 600 mg and 900 mg groups walked the furthest. Blood "biological age" — calculated by the Aging.AI 3.0 algorithm from 19 lab markers, stayed flat in NMN groups while rising in placebo. This is the strongest "anti-aging" signal in any NMN RCT to date, and it's a surrogate marker, not a lifespan measurement.

What happens beyond month 3?

No published RCT followed humans beyond 24 weeks (Akasaka 2022). Claims about skin reversal at month 3 or "youthful glow" at month 6 are not from human data, they're from anecdotal user reports or mouse trials. Take them at face value: anecdotal.

What 4 Major Human RCTs Actually Found

Four human RCTs found NMN reliably raises blood NAD+ and produces modest functional gains: improved insulin sensitivity in prediabetic women at 250 mg/day, better walking endurance and six-minute-walk distance, and small strength changes. No serious safety signals appeared, but effects were measurable rather than transformative.

Documented human NMN outcomes: improved muscle insulin sensitivity in prediabetic women at 250 mg/day over 10 weeks (PMID: 33888596), increased walking endurance in middle-aged adults, and elevated blood NAD+ within 2–4 weeks across trials. Not documented: visible anti-aging changes, lifespan extension, or cosmetic effects — those remain extrapolations from animal data.

According to Dr. Andrea Maier, Professor and Co-Director of the Centre for Healthy Longevity at the National University of Singapore and senior author of Yi 2023, "Clinical efficacy expressed by blood NAD+ concentration and physical performance reaches highest at a dose of 600 mg daily oral intake." That 600 mg ceiling is the most defensible number in the entire NMN literature.

Does NMN Really Work? The Honest Verdict

If "work" means raising blood NAD+: yes, demonstrably, in every human trial.

If "work" means raising blood NAD+: yes, demonstrably, in every human trial. If "work" means measurable functional gains in adults over 40: the answer got weaker between 2024 and 2026, not stronger — individual trials found isolated improvements, but pooled analyses have mostly not confirmed them. If "work" means visibly looking younger, regrowing hair, or living longer: no human RCT has shown that, and anyone telling you otherwise is selling something.

The honest summary: NMN is one of the few longevity supplements with multiple positive human RCTs. The effect sizes are small. The trials are small. The mechanism is plausible. That is roughly where the field stands in 2026.

How the 2024–2026 evidence changed this picture

Between 2024 and 2026, four meta-analyses and two new RCTs on NMN were published. The blood NAD+ finding held up. Several of the functional-benefit findings did not. Individual trials had reported improvements in muscle, glucose, and lipid measures; when those trials were pooled, most of those improvements lost statistical significance. We have updated this article to show the current numbers.

Muscle mass and strength: pooled evidence is negative

Prokopidis et al., 2025, in Journal of Cachexia, Sarcopenia and Muscle, pooled the randomised trials of NMN and NR against placebo in adults with a mean age of 61 to 83. NMN showed no significant effect on skeletal muscle index, handgrip strength, gait speed, or the five-times chair-stand test. The narrative synthesis found no improvement in knee-extension strength, short physical performance battery score, or thigh muscle mass either. The authors' conclusion is blunt: current evidence does not support NMN or NR for preserving muscle mass and function in this age group.

That result qualifies the single-trial grip-strength and gait-speed findings described earlier on this page. Those trials reported what they reported. Combined with the others, the effect disappears.

Glucose and lipids: no pooled benefit

Chen et al., 2024, in Current Diabetes Reports, pooled eight RCTs covering 342 mostly non-diabetic middle-aged and older adults at 250–2,000 mg/day for 14 days to 12 weeks. There was no significant benefit on fasting glucose, fasting insulin, HbA1c, HOMA-IR, or lipid profile. Yang et al., 2026, in Nutrients, reached the same conclusion across fifteen trials, finding no significant change in body weight, BMI, fasting glucose, HbA1c, lipids, or systolic blood pressure.

The Yoshino 2021 insulin-sensitivity result remains the strongest single positive metabolic finding, but it was measured by hyperinsulinaemic clamp in 25 prediabetic postmenopausal women — a specific population and a more sensitive method than the fasting markers the meta-analyses pooled.

Blood pressure: a small but real signal

Zhang et al., 2026, in Nutrients, pooled ten RCTs and 349 participants. NMN was associated with a statistically significant reduction in resting diastolic blood pressure of 2.15 mmHg (95% CI −3.68 to −0.61). Systolic pressure did not move significantly overall, but in participants aged 60 and over it fell by 3.94 mmHg (95% CI −7.06 to −0.82). Yang 2026 independently observed the same small diastolic decrease. Two independent pooled analyses agreeing is a stronger footing than most NMN claims have.

Walking speed and sleep: a trial that missed its primary endpoint and hit its secondary ones

Morifuji et al., 2024, in GeroScience, randomised 60 older adults to 250 mg/day NMN or placebo for 12 weeks. The primary endpoint, a stepping test, showed no significant difference at either 4 or 12 weeks. The secondary endpoints did: 4-metre walking time was significantly shorter than placebo at 12 weeks, blood NAD+ and its metabolites were significantly higher, and sleep quality improved on the Pittsburgh Sleep Quality Index, specifically the daytime-dysfunction and global scores. The change in walking time correlated negatively with the change in blood NAD+.

Secondary endpoints carry less weight than primary ones, and a trial that misses its primary endpoint is not a positive trial in the strict sense. We list it because it is the most recent walking-and-sleep data available and because the NAD+ correlation is mechanistically consistent with the rest of the literature.

What actually survives

Three claims hold up under the 2026 evidence base. Blood NAD+ rises reliably and dose-dependently. The safety profile is clean — Yang 2026 found no increase in overall, serious, or withdrawal-related adverse events, and no elevation of ALT or AST across doses from 250 to 2,000 mg/day. And diastolic blood pressure falls slightly, with a larger systolic effect in people over 60.

Everything else in the NMN literature is either single-trial, population-specific, or has failed to replicate under pooling. If you are deciding whether to take NMN, that is the honest state of the evidence as of 2026 — better characterised for safety than for benefit.

What do NMN users actually report?

Online user reports skew toward two patterns.

Online user reports skew toward two patterns. The first group, typically adults over 50, often supplementing alongside resveratrol — reports steadier afternoon energy by week 3 and easier mornings by week 6. The second group, usually younger, healthier users, reports either nothing or mild GI discomfort and quits within a month. Both patterns line up with the trials: NMN does more in people with depleted NAD+ baselines.

Reddit threads on r/NMN and r/longevity skew enthusiastic, partly because people who don't notice anything stop posting. Treat any "I felt amazing within 3 days" testimonial as either placebo, expectancy effect, or that person taking too much caffeine. The biology takes longer than three days.

Does the precursor you choose change your before-and-after results?

The precursor you choose may change your results: a 2025 head-to-head trial showed NR raised blood NAD+ roughly 2.3× more than NMN at equivalent doses. This is the core argument of NMN's most prominent critic, City of Hope biochemist Charles Brenner, who discovered NR in 2004. His core argument: NMN must be converted to NR before crossing cell membranes in most tissues, which means NMN supplementation is essentially "NR with an extra step." A 2025 head-to-head trial showed NR raised blood NAD+ roughly 2.3× more than NMN at equivalent doses.

The counter-position: the Slc12a8 transporter identified by Imai's group allows NMN to enter cells directly in the gut. Whether that pathway dominates in other tissues is unresolved. Brenner is also Chief Scientific Advisor to ChromaDex, which sells Tru Niagen NR, a conflict he discloses openly. Dr. David Sinclair, NMN's most prominent advocate, co-founded MIB Biotech, which is developing a prescription NMN. Both sides have skin in the game.

For most consumers, the practical answer: at 500–600 mg/day, NMN raises NAD+ enough to drive the functional outcomes measured in trials. Whether NR would do it "more efficiently" is a question of biochemistry, not necessarily outcomes. Read our full breakdown in NMN vs NR: which NAD+ precursor is better. Our best NAD+ supplements compared guide ranks both precursors by trial evidence.

What NMN Won't Do

Honesty about limits is what separates evidence from marketing.

Honesty about limits is what separates evidence from marketing. It will not extend your lifespan. Zero human longevity trials exist. Mouse data is suggestive but doesn't transfer cleanly, mice live 2 years, humans 80. It will not reverse visible aging in 30 days. Skin elasticity claims at month 1 are from rodent histology, not human dermatology RCTs.

• It will not extend your lifespan. Zero human longevity trials exist. Mouse data is suggestive but doesn't transfer cleanly, mice live 2 years, humans 80.
• It will not reverse visible aging in 30 days. Skin elasticity claims at month 1 are from rodent histology, not human dermatology RCTs.
• It will not replace exercise or sleep. Liao 2021 only saw aerobic gains in trained runners, the supplement amplified training, didn't substitute for it.
• It will not work the same for everyone. Yi 2023's post-hoc analysis found wide individual variation in NAD+ response, especially at 300 mg.
• It will not regrow hair. No published human trial has measured hair density on NMN.

How YourHealthier NMN Compares

NMN supplements vary widely in dose, purity, and cost per effective serving.

NMN supplements vary widely in dose, purity, and cost per effective serving. Product comparison: dosage, testing, and value across leading brands Brand Form NMN per serving Third-party COA Notes YourHealthier NMN Capsule 500 mg Yes, batch-level Aligned with Yi 2023's 600 mg sweet spot via 1 cap + meal-derived NAD+ precursors Tru Niagen (ChromaDex) Capsule 300 mg NR (not NMN) Yes NR, not NMN —

Our NMN 500 mg sits at the dose Yoshino 2021 used (250 mg) doubled, and at the bottom of Yi 2023's tested range (300–900 mg). Two capsules a day gets you to 1,000 mg, within the safety envelope established by Liao 2021's 1,200 mg arm. See our third-party lab results.

What's the optimal NMN dose for results?

The optimal NMN dose for most people is around 600 mg/day. In the Yi (2023) RCT, 600 mg gave the best balance of NAD+ elevation and functional gains, while 900 mg added little. Start lower to gauge tolerance, then hold a steady daily dose.

The honest dose range from the human RCTs: 250 mg/day is the minimum that's been shown to do anything (Yoshino 2021, Igarashi 2022). 600 mg/day is where Yi 2023 found the efficacy ceiling. 900–1,200 mg/day adds cost without proportional benefit.

If you're under 40 and healthy, start at 250–500 mg/day. If you're over 50 and feeling cellular slowdown, 500–600 mg/day matches the strongest evidence. Above 900 mg/day, you're past the diminishing-returns curve — no human trial has shown additional functional gain.

For the full dose breakdown, read our NMN dosage guide. For timing, see best time to take NMN.

Who might not see NMN before-and-after results?

NMN has a strong safety record across the published RCTs, no serious adverse events at doses up to 1,200 mg/day for 6 weeks. Still, certain groups should consult a healthcare professional before starting:

• Anyone with an active cancer diagnosis or history. NAD+ is required for cell metabolism, and some preclinical work suggests NAD+ boosters could theoretically support tumor growth. The clinical evidence is unclear; the conservative move is to defer to your oncologist.
• People on dialysis or with significant kidney impairment. A 2024 mouse study raised questions about NAD+ metabolite buildup in compromised kidneys. The mouse data is preliminary, but kidney patients should ask their nephrologist first.
• Pregnant or breastfeeding individuals. No safety data in these populations.
• People taking nicotinamide riboside (NR) or niacin already. Stacking NAD+ precursors hasn't been studied in humans for safety.
• Children and adolescents. NAD+ does not need to be supplemented in growing bodies with high baseline levels.

How to Track Your Own NMN Before and After

NAD+ Before and After: What to Expect from NAD Supplementation

Whether you boost NAD+ through oral NMN or direct delivery, the timeline for noticeable changes is similar.

Whether you boost NAD+ through oral NMN or direct delivery, the timeline for noticeable changes is similar. NAD+ before and after reports from users typically describe improved energy within 1–2 weeks, better sleep quality by week 3–4, and cognitive clarity improvements over 4–8 weeks. Those using NAD injections before and after protocols often report faster initial response due to direct bioavailability, while NAD IV before and after experiences tend to show the most dramatic short-term energy improvements—though these are temporary without ongoing supplementation.

Subjective feelings are unreliable on a 12-week timescale. If you're going to spend $30–60/month on NMN, measure what you're getting. Blood NAD+ test — Jinfiniti and TruDiagnostic both offer at-home finger-prick tests. Baseline before starting, retest at week 6 and week 12. This is the only direct measure.

• Blood NAD+ test — Jinfiniti and TruDiagnostic both offer at-home finger-prick tests. Baseline before starting, retest at week 6 and week 12. This is the only direct measure.
• Resting heart rate. Average overnight HR via Apple Watch / Oura / Whoop. A 2–4 bpm drop over 8 weeks is plausible if NMN is improving cardiovascular efficiency.
• Walking speed. Time a quarter-mile flat walk. Yi 2023's strongest functional finding was on the 6-minute walk test.
• HRV (heart rate variability) — Same wearables. Trends matter more than individual days.
• Skin photos. Same lighting, same time of day, monthly. Not because NMN reliably changes skin, but because if it does for you, you'll want the record.

Establish a 7-day baseline before starting. Reassess at week 4, 8, and 12. If you see no change in any objective marker by week 12, you're probably a non-responder, discontinue or switch to NR.

What should you stack NMN with?

NMN works on the NAD+ pathway.

NMN works on the NAD+ pathway. Pairing it with supplements targeting other cellular systems is what most longevity protocols do: The premise: NMN raises NAD+, resveratrol activates sirtuins that use NAD+. Human evidence for the combination is thin but by mechanism coherent. Berberine 1500 mg , for metabolic support via AMPK activation.

• NMN + resveratrol — David Sinclair's stack. The premise: NMN raises NAD+, resveratrol activates sirtuins that use NAD+. Human evidence for the combination is thin but by mechanism coherent.
• Berberine 1500 mg, for metabolic support via AMPK activation. See berberine benefits and berberine + magnesium stack.
• Ashwagandha KSM-66, chronic cortisol depletes NAD+. Lowering cortisol preserves what NMN replenishes. See ashwagandha for cortisol.
• Magnesium Glycinate — NAD+ regenerates during deep sleep. See magnesium glycinate sleep research.
• Creatine Hydration Powder, for muscle ATP support that NMN alone won't deliver. See creatine benefits beyond muscle.
• Lion's Mane 1000 mg, for cognitive support via Nerve Growth Factor, a different pathway than NMN's. See lion's mane benefits.
• Shilajit Adaptogen Complex — provides fulvic acid and trace minerals that support mitochondrial function alongside NMN.

Why YourHealthier Made a 500 mg NMN

We picked 500 mg per capsule because it lets users hit the most-studied doses without splitting capsules.

We picked 500 mg per capsule because it lets users hit the most-studied doses without splitting capsules. One capsule a day matches Yoshino 2021 (doubled). Two capsules matches Liao 2021's medium and Yi 2023's high-end. Three capsules approaches Liao 2021's 1,200 mg ceiling, the highest dose with documented safety data over 6 weeks.

The bottle carries batch-level Certificate of Analysis confirming >99% purity by HPLC. No fillers beyond what's needed for capsule integrity. No proprietary blends, what's on the label is what's in the capsule. See our Editorial Policy for how every claim on this page was sourced and reviewed.

What is an NMN supplement, and what should I expect?

NMN (nicotinamide mononucleotide) is an NAD+ precursor taken to support cellular energy that declines with age. In trials, blood NAD+ roughly doubles by week 8 at 250 to 600 mg daily, while felt changes such as energy or walking endurance are gradual and vary between people.

NMN Background: Why People Try It

Here is the one number that matters: in trials, blood NAD+ roughly doubles by week 8 on 250 to 600 mg of NMN daily. NMN (nicotinamide mononucleotide) is a precursor the body converts into NAD+, the coenzyme that powers cellular energy and falls with age. Raising NAD+ is the entire point of taking it.

Our Batch-Level Purity Testing

Manufactured in a UL Solutions GMP-certified facility (Retail Certification Program Requirements, certification valid through November 12, 2028). Every batch of NMN undergoes independent third-party testing at a cGMP-compliant third-party laboratory for heavy metals and microbial contamination. Lot 6020213 (COA issued 04/29/2026) passed every safety threshold.

Testing performed using validated analytical methods per cGMP requirements. The data below reflects batch-specific results — not general ingredient claims — verified under current Good Manufacturing Practices (21 CFR Part 111).

Testing performed by cGMP-compliant third-party laboratory. Serving size: 1 Capsule. Manufacturing date: 03/03/2026. Full batch results: yourhealthier.com/pages/lab-results. Original certificates of analysis available upon request.

Testing & Transparency Methodology

Every YourHealthier product referenced here is manufactured in an FDA-registered facility and undergoes independent third-party testing at accredited laboratories (ISO/IEC 17025, A2LA, or Eurofins, depending on the product). Each batch is screened for heavy metals (lead, cadmium, mercury, arsenic) and microbial contamination (total plate count, yeast, mold, E. coli, Salmonella) using validated USP, AOAC, and ICP-MS methods. Batch-specific certificates of analysis are published at yourhealthier.com/pages/lab-results and updated with each new manufacturing run. All testing complies with current Good Manufacturing Practices (21 CFR Part 111). This article is written for general educational purposes and is not medical advice; it has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

References

All studies cited in this article are hyperlinked to their original PubMed or journal entries at first mention. Full citations are provided in-text for transparency and verification.

Related Research

• PubMed: 27721479
• PubMed: 36476934
• PubMed: 27304511
• PubMed: 35821806
• DOI: 10.1002/fft2.511
• PubMed: 17086191
• PubMed: 36144285

Related Reading

• NAD+ supplements: complete guide
• NAD+ injections: benefits and evidence
• NAD+ IV therapy: costs and evidence
• NMN and Resveratrol: Sinclair's Stack, Honestly Reviewed
• NMN vs NAD: What's the Difference? (2026 Science Guide)
• Best Time to Take NMN: Morning or Night? (2026 Guide)
• NMN Side Effects: What the Clinical Trials Report (2026)
• NMN vs NR: Which NAD+ Precursor Is Better? (2026 Data)
• NMN Dosage: How Much Per Day? 250mg vs 600mg vs 1000mg
• NMN Benefits: NAD+ for Aging & Energy (2026)

What do the newest NMN trials report for measurable results?

The NMN trial count cleared a dozen published RCTs by 2026, spanning dose ranges from 250 mg to 1,250 mg daily. The consistent finding: NAD+ levels go up, side effects stay mild, and longer-duration data is still the gap to watch.

What realistic NMN before-and-after changes look like at 8 weeks

The NMN "before and after" narrative on social media typically features dramatic claims: reversed gray hair, eliminated wrinkles, 20 years of biological age reversal. The clinical trial data paints a different, more modest, but genuinely interesting picture.

Blood NAD+ levels: The most consistent and measurable before-and-after change. The Igarashi 2022 trial documented NAD+ increases of 40 to 50% above baseline at 250 mg/day after 12 weeks. This is objectively measurable through specialty blood testing and represents the most reliable marker that NMN is doing what it claims.

Physical function: The Kim 2022 trial gave 250 mg/day to older Japanese adults for 12 weeks and found improved five-times sit-to-stand performance and reduced daytime drowsiness, with the largest effect in the afternoon-dosing arm. Six-minute walk distance is a separate finding, from Yi 2023 at 600–900 mg/day. The magnitude was modest (approximately 30 to 50 meters improvement) but statistically significant. This translates to slightly less breathlessness during daily activities like climbing stairs or walking uphill.

Insulin sensitivity: The Yoshino 2021 trial found improved muscle insulin sensitivity in postmenopausal women with prediabetes after 10 weeks at 250 mg/day. This is a metabolic improvement that does not produce visible "before and after" changes but reduces long-term cardiometabolic risk.

Sleep quality: Some trials report improved sleep scores as a secondary endpoint. The mechanism: NAD+ supports sirtuin-mediated circadian clock function, which may improve sleep-wake cycle regularity. This is not a dramatic "before and after". It is a gradual shift from "I wake up tired" to "I wake up slightly less tired" over weeks.

What you will NOT see at 8 weeks: Visible skin rejuvenation, reversed hair graying, dramatic energy transformation, weight loss, or anything that produces a compelling before-and-after photograph. The Yi 2023 trial measured six-minute walking distance and NAD+ levels by instrument but noted the change was not visible to the naked eye. Anyone claiming dramatic visual NMN transformations at 8 weeks is either experiencing placebo, attributing other lifestyle changes to NMN, or fabricating results.

For the dosing protocol that these trials used: see NMN dosage. For the side effect profile: NMN side effects. For the comparison with NR: NMN vs NR.

How do you design your own NMN experiment?

If you want to evaluate NMN for yourself rather than relying on population-level trial data, a structured self-experiment produces the most useful personal data.

If you want to evaluate NMN for yourself rather than relying on population-level trial data, a structured self-experiment produces the most useful personal data. Baseline (4 weeks, no NMN): Track daily: energy level (1-10 at 3 PM), sleep quality (1-10 on waking), exercise recovery (subjective scale), and any specific metric relevant to your goals.

Phase 1. Baseline (4 weeks, no NMN): Track daily: energy level (1-10 at 3 PM), sleep quality (1-10 on waking), exercise recovery (subjective scale), and any specific metric relevant to your goals. If possible, get blood work: NAD+ levels (Jinfiniti or equivalent), fasting glucose, lipid panel, hsCRP. This 4-week baseline captures natural variation and establishes the range your metrics fluctuate without any intervention.

Phase 2. NMN intervention (12 weeks, 500 mg/day with morning breakfast): Continue tracking the same metrics with the same methodology. Do not change any other variable (diet, exercise, sleep schedule, other supplements) during this phase. At week 12, repeat the blood work. Compare Phase 2 averages to Phase 1 averages.

Phase 3 — Washout (4 weeks, no NMN): Continue tracking. If improvements reverse during the washout (energy declines, sleep quality decreases, NAD+ levels return to baseline), the changes during Phase 2 were likely NMN-mediated rather than coincidental. If metrics remain improved during washout, the improvement may have been lifestyle drift or placebo.

This A-B-A design is the gold standard for n=1 experiments and provides far more reliable personal data than the typical approach of "I started NMN and felt better." The 20-week total commitment is substantial, but the result is genuine knowledge about whether NMN works for your individual physiology, worth more than any number of internet testimonials. For the dose protocol: NMN dosage.

Which blood biomarkers track NMN's effects?

For people who want objective proof rather than subjective impressions, blood biomarker tracking provides the most reliable NMN before-and-after comparison. The key markers to test at baseline and at 12 weeks:

NAD+ levels (primary marker): Specialty tests from companies like Jinfiniti measure whole blood NAD+ concentration. A 40 to 100% increase from baseline confirms that your NMN supplement is doing what it claims. If NAD+ does not increase, the product may be degraded, underdosed, or your absorption may be impaired.

Fasting insulin and glucose: The Yoshino 2021 trial found improved insulin sensitivity. A decrease in fasting insulin with stable glucose suggests improved insulin efficiency. HOMA-IR (calculated from fasting glucose and insulin) provides a single number that captures insulin resistance status.

Inflammatory markers (hsCRP, IL-6): NAD+ supports sirtuin-mediated anti-inflammatory pathways. A decrease in inflammatory markers from baseline suggests the NAD+ elevation is producing downstream anti-inflammatory effects.

Lipid panel: Some NMN trials have found modest improvements in triglycerides and LDL-C, consistent with improved metabolic function.

The total cost of this biomarker panel is approximately $200 to $400 (baseline + 12-week retest), which is a meaningful investment alongside the $50 to $100/month cost of NMN supplementation. But it provides definitive personal data that no amount of subjective reporting can match. If your NAD+ doubles and your inflammatory markers improve, NMN is working for you, regardless of whether you "feel" different. If your markers do not change, you can discontinue with confidence rather than continuing to spend on hope.

Can you trust NMN before-and-after photos?

Social media is filled with NMN "before and after" photos showing dramatic skin improvements, weight loss, or apparent age reversal.

Social media is filled with NMN "before and after" photos showing dramatic skin improvements, weight loss, or apparent age reversal. The methodological problems with these photos make them essentially worthless as evidence. Lighting differences between photos (natural versus artificial, morning versus evening) change apparent skin texture and tone by 20 to 40%. Camera angle shifts of even 5 degrees alter facial proportions and perceived skin tightness. Weight fluctuations of 2 to 3 kg (normal daily variation from hydration and food) change facial fullness dramatically. Skincare routine changes, Botox, fillers, or other cosmetic procedures between photos are rarely disclosed. Seasonal skin changes (winter dryness versus summer glow) produce visible differences that have nothing to do with supplements.

The Yi 2023 trial measured six-minute walking distance with standardized protocols (Cutometer) in a controlled environment and found improvement, but noted the change was not visible to the naked eye. If a controlled clinical instrument can barely detect the skin change from NMN, your iPhone camera in different lighting absolutely cannot. Any dramatic visual NMN transformation on social media is attributable to photography variables, not NMN pharmacology.

The honest before-and-after: blood biomarkers (NAD+ levels, insulin sensitivity, inflammatory markers) measured in a clinical lab under standardized conditions. These provide genuine, reproducible evidence of NMN's effects that no lighting trick can replicate. See the biomarker tracking protocol above for the specific tests and timeline.

Frequently Asked Questions

References (all human RCTs unless noted):

1. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. PMID: 33888596
2. Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood NAD levels and alters muscle function in healthy older men. npj Aging. 2022;8(1):5. PMID: 35927255
3. Liao B, Zhao Y, Wang D, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18(1):54. PMID: 34238308
4. Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29–43. PMID: 36482258
5. Kim M, Seol J, Sato T, Fukamizu Y, Sakurai T, Okura T. Effect of 12-week intake of NMN on sleep quality, fatigue, and physical performance in older Japanese adults. Nutrients. 2022;14(4):755. PMID: 35215405
6. Klein S, Yoshino M. Response to Comment on "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;373(6554):eabj7375. PMID: 34326209 (response to Arena's randomization critique, PMID: 34326206)

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not intended as medical advice.

NMN Before & After: The Timeline

Metric	Value
NAD+ doubles by week	250-600 mg
Efficacy ceiling (Yi 2023)	600 mg/day
NAD+ rises within	days
Functional gains at	week 6–12
Source: YourHealthier · Yi 2023 dose-response RCT (n=80)

Chart: NMN Before & After: The Timeline. Data: NAD+ doubles by week: 250-600 mg; Efficacy ceiling (mg/day): Yi 2023; NAD+ rises within (days): first days; Functional gains (weeks): later. Source: Yi 2023 dose-response RCT (n=80).